Pfizer shares climb on speculation of unit sales

Pfizer and StemCells stocks both gain in early action as the drug sector’s two key indexes move sluggishly.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.